(2026). Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: Retention and discontinuation factors in a UK six-centre cohort. Rheumatology Advances in Practice.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Real-world Experience with Janus Kinase Inhibitors in Rheumatoid and Psoriatic Arthritis: Retention and Discontinuation Factors in a UK Six-centre Cohort."
Rheumatology Advances in Practice 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Real-world Experience with Janus Kinase Inhibitors in Rheumatoid and Psoriatic Arthritis: Retention and Discontinuation Factors in a UK Six-centre Cohort."
Rheumatology Advances in Practice, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.